Brief: Resverlogix announces extension of maturity date of loan and expression of interest on strategic transaction
28/08/2017 12:01
Aug 28 (Reuters) - Resverlogix Corp RVX.TO
* Resverlogix announces extension of maturity date of loan
and expression of interest regarding strategic transaction
* Resverlogix corp - maturity date of company's CAD$68.8
million loan will be extended from august 28, 2017 to December
26, 2017
* Resverlogix Corp - loan is secured by an irrevocable
CAD$68.8 million standby letter of credit in favour of lender
arranged by Eastern Capital Limited
* Resverlogix Corp - received a letter of intent regarding a
significant potential regional licensing arrangement for
Apabetalone (RVX-208)
* Resverlogix Corp - license is expected to include an
upfront payment and on-going milestone and royalty payments
Source text for Eikon: ID:nPn1hPBg8a
Further company coverage: RVX.TO
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Resverlogix
See all newsBrief: Resverlogix Confirms Focus On Treatment Of Post Covid-19 Conditions
Brief: Resverlogix Announces New Research Findings Highlighting Safety Of BD2-Selective BET Inhibitors
Brief: Resverlogix Announces Type C Meeting With FDA For Coral, A Phase 3 High-Risk Covid-19 Outpatient Study
Brief: Resverlogix Expands Phase 2B Clinical Trial For Covid-19 Treatment With First Site In Brazil And Second In Canada
Brief: Resverlogix Announces Commencement Of Patient Enrollment And Dosing In A Phase 2B Trial For COVID-19 Treatment